Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its Concierge Medical business provides discreet and personalized concierge healthcare services, including IV Vitamin Therapy. Its services include Screenpro Security, Justera Health Product, Naturevan, Juillet Wellness, and TRINITI Corporation. It is also specialized in providing efficient COVID-19 testing and same-day test results through its Canadian labs. It offers two convenient methods to test: in clinic testing or mobile at home testing. It is a distributor of TonyMoly skin care products in Canada. It provides a full-service wellness center, providing a range of beauty and wellness services.


CSE:VTAL - Post by User

Post by Smokey1958on Oct 16, 2021 10:19am
300 Views
Post# 34013304

Let’s Not Forget This!!!

Let’s Not Forget This!!!

This from a Datametrex September NR referencing a covid testing agreement:

"The company has recorded revenue of approximately $26 million for the first nine months of the agreement, exceeding expectations and showcasing the company’s ability to meet this need.

Given the increased demand around COVID-19 testing for new and returning shows, Datametrex now anticipates that the agreement will generate up to $50 million for the full fiscal year."

The connection and benefit to SCRN of this agreement and therefore this updated forecast has been and is well established. Looking forward to some updates from ScreenPro management.


 

<< Previous
Bullboard Posts
Next >>